Champions Oncology
CSBR
38 hedge funds and large institutions have $68.5M invested in Champions Oncology in 2021 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 16 reducing their positions, and 12 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4.07% less ownership
Funds ownership: 53.78% → 49.71% (-4.1%)
16% less funds holding
Funds holding: 45 → 38 (-7)
16% less capital invested
Capital invested by funds: $81.3M → $68.5M (-$12.9M)
50% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 16
58% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$895K |
| 2 |
RC
Roubaix Capital
Denver,
Colorado
|
+$732K |
| 3 |
E
Ergoteles
New York
|
+$313K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$293K |
| 5 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
+$288K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$3.68M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.39M |
| 3 |
State Street
Boston,
Massachusetts
|
-$784K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$621K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$545K |
CSBR Hedge Fund Activity: Q2 2021 in Review
38 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q2 2021, worth a combined $68.5M — down 16% from $81.3M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of CSBR and 5 opened new positions — a net loss of 7 holders — while 16 trimmed existing stakes and 8 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $895K. The largest seller was BlackRock, cutting an estimated $3.68M.
- 38 institutional investors held Champions Oncology (CSBR) as of Q2 2021, down from 45 in Q1 2021.
- Funds reported $68.5M of Champions Oncology stock for Q2 2021, down 16% quarter-over-quarter.
- 5 funds opened new Champions Oncology positions in Q2 2021 and 12 closed out, a net change of -7 holders.
- The largest Champions Oncology buyer in Q2 2021 was Millennium Management, an estimated $895K added.
- The largest Champions Oncology seller in Q2 2021 was BlackRock, an estimated $3.68M sold.
Based on aggregated 13F filings for Q2 2021.